RxDoctor Payments Data

Nadia Zandy

Psychiatric/Mental Health · Philadelphia, PANPI 1164137519

Payments from drug & device makers

$5,973in general payments, 2019–2025

Across 285 payments — averaging $20.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$814
  • AbbVie$765
  • Axsome Therapeutics, Inc.$624
  • Otsuka America Pharmaceutical, Inc.$569
  • Neurocrine Biosciences, Inc.$487
  • Alkermes, Inc.$438
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$5,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,973 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl21$29,564
RexultiBrexpiprazole12$17,307
Lurasidone Hcl20$5,378
Aripiprazole86$4,911
Duloxetine Hcl64$2,312
Buspirone Hcl141$1,871
Quetiapine Fumarate97$1,312
Olanzapine81$1,311
Divalproex Sodium45$1,208
Atomoxetine Hcl29$1,180
Haloperidol51$1,172
Trazodone Hcl140$1,006
Carbamazepine19$938
Venlafaxine Hcl ErVenlafaxine Hcl17$766
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$761

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$765$29,56421 claims
Otsuka America Pharmaceutical, Inc.Rexulti$569$17,30712 claims
Almatica Pharma LLCSertraline Hcl$86$42988 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →